Welcome to Ikonisys SA ALIKO SCIENTIFIC
Investor Relations website
We are a listed company on Euronext Growth Paris
Proud Science PioneersOur mission is making accessible
CANCER DIAGNOSTICS
Check our latestPress Releases
LEARN MORE
ABOUT OUR GROUP
Group Structure
ALIKO SCIENTIFIC
Aliko Scientific SA (formerly Ikonisys SA)
The corporate hub, coordinating R&D, business development and partnerships, financial activities and strategic acquisitions.
Ikonisys
A world leader in automated molecular cancer diagnostics, with advanced high-precision microscopic imaging
and artificial intelligence software.
Hospitex
A world leader in precision cytology, recognised for its innovative sample standardisation technology.
The corporate hub, coordinating R&D, business development and partnerships, financial activities and strategic acquisitions.
Ikonisys
A world leader in automated molecular cancer diagnostics, with advanced high-precision microscopic imaging
and artificial intelligence software.
Hospitex
A world leader in precision cytology, recognised for its innovative sample standardisation technology.
Ikonisys.
Finding the cells that matter.
Fluorescence In Situ Hybridization technology provides a high level of sensitivity and specificity in detecting genetic abnormalities, allowing for precise identification of chromosomal alterations associated with various cancers.
This aids in accurate cancer diagnosis and classification.
Overall, the use of FISH technology empowers pathologists with valuable diagnostic and prognostic information, ultimately leading to improved patient care and outcomes in oncology.
This aids in accurate cancer diagnosis and classification.
Overall, the use of FISH technology empowers pathologists with valuable diagnostic and prognostic information, ultimately leading to improved patient care and outcomes in oncology.
HOSPITEX.
The Cytology Company.
Liquid-based cytology (LBC) is an advanced technique for detecting abnormal cells, especially in cervical cancer screening. Unlike traditional methods, LBC provides clearer and more reliable samples.
The advantages of LBC include improved accuracy and reliability in detecting abnormal cells, such as those associated with cervical cancer. The process reduces the likelihood of inadequate or unclear samples, leading to more accurate diagnostic results. Additionally, Hospitex LBC allows for the use of the same sample for further testing, such as HPV (Human Papillomavirus) testing, without the need for additional sample collection.
Hospitex is the leading company in LBC, offering solutions that improve diagnostic accuracy and patient outcomes.
The advantages of LBC include improved accuracy and reliability in detecting abnormal cells, such as those associated with cervical cancer. The process reduces the likelihood of inadequate or unclear samples, leading to more accurate diagnostic results. Additionally, Hospitex LBC allows for the use of the same sample for further testing, such as HPV (Human Papillomavirus) testing, without the need for additional sample collection.
Hospitex is the leading company in LBC, offering solutions that improve diagnostic accuracy and patient outcomes.
LBC Cytology integrated with FISH automation deliversWe integrate different Technologies
to achieve the best Diagnostic Solutions
ALIKO SCIENTIFIC
Our Mission is detecting Cancer
Our mission is to advance cancer diagnostics through in-depth cellular investigation, enabling the precise detection and understanding of cellular abnormalities.
By doing so, we aim to drive the development of targeted treatments and improve patient outcomes
By doing so, we aim to drive the development of targeted treatments and improve patient outcomes
Automation
The integration of automation in FISH technology empowers technicians with improved efficiency, consistency, and quality in diagnostic testing, ultimately leading to enhanced patient care outcomes.
Digitization
Acquire fluorescence images of all the desired cells or tissue present on the slide and the diagnostic signals that they contain.
Analysis & Interpretation
Analyze and interpret the acquired images in a both qualitative and quantitative fashion; enumerating, classifying and presenting diagnostically relevant cells for review, without user intervention, as an adjunct to diagnosis.
Compliance and QualityTOTAL RELIABILITY
FDA & IVDR Cleared Products
The companies within the group have successfully attained all major certifications, including FDA and IVDR approvals. This achievement underscores their commitment to meeting the highest standards of quality, safety, and compliance in the field of cancer diagnostics.
Our satisfied
clients
Thank you for choosing ALIKO SCIENTIFIC products.
We look forward to continuing to serve you and to contributing to your success in the Pathology Diagnostics.
We look forward to continuing to serve you and to contributing to your success in the Pathology Diagnostics.
More than 1 Million of Cancer Diagnostic Reports Done with our Technology
Our advanced genetic testing platform has undergone extensive validation in thousands of real-world scenarios, confirming its reliability across a wide range of conditions and applications.
From disease diagnosis to personalized medicine, our platform has been proven to deliver consistent and accurate results, providing peace of mind to both healthcare professionals and patients alike.
0123456789001234567890
Scientist, Researchers and Engineers
0123456789001234567890
Years of Development and experience
0123456789001234567890 .012345678900123456789001234567890
Hours of testing and fine tuning
With our commitment to excellence and quality assurance, you can trust that our genetic testing platform will meet your highest standards for reliability and accuracy.
Experience the difference that thousands of tests performed can make with Ikonisys.
Contact us today to learn more.
We are at the forefront of innovation Liquid biopsy / CTC
Circulating Tumor Cells
CTC (Circulating Tumor Cells) analysis is crucial in cancer research and treatment, offering a non-invasive method for early detection, monitoring disease progression, and tailoring personalized therapeutic strategies. Using FISH (Fluorescence In Situ Hybridization) technology for CTC (Circulating Tumor Cells) detection enhances the ability to identify and characterize genetic abnormalities in cancer cells, facilitating precise, non-invasive diagnosis and targeted treatment strategies.
Get in touch
Come and visit our quarters or simply send us an e-mail: info@alikoscientific.com
Legal Headquarters
Aliko Scientific SA
rue de Caumartin,62
75009 Paris, France
rue de Caumartin,62
75009 Paris, France
Corporate Headquarters
Aliko Scientific Srl
Via dell'Ambrosiana, 22
20123 Milano, Italy
Via dell'Ambrosiana, 22
20123 Milano, Italy
Operating Headquarters
Aliko Scientific Srl
Via Massimo D'Antona, 17
50019 Sesto Fiorentino (FI), Italy
Via Massimo D'Antona, 17
50019 Sesto Fiorentino (FI), Italy
DISCOVER OUR GROUP
CONTACTS
Aliko Scientific SA (formerly Ikonisys SA)
62, rue de Caumartin
75009 Paris
Email: investor@alikoscientific.com
TVA : FR38899843239
RCS : 899 843 239 R.C.S. Paris
EORI: FR89984323900018
ALIKO SCIENTIFIC
IKONISYS
HOSPITEX
Copyright by Aliko Scientific SA (formerly Ikonisys SA). All rights reserved.